Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
Friday, March 22, 2013
Current research developments and future healthcare solutions are expected to be closely linked to the utility of biobank initiatives.
Genetic Analysis of UK Biobank Participants
Friday, March 22, 2013
UK Biobank announces plans to undertake detailed DNA analysis of its 500,000 participants to better understand the complex interaction of lifestyle and genes in causing life-threatening and disabling disorders.
IUPUI Stem Cell Research Could Expand Clinical Use of Regenerative Human Cells
Friday, March 22, 2013
Research has uncovered a method to produce retinal cells from regenerative human stem cells without the use of animal products, proteins or other foreign substances.
Stem Cells Entering Heart can be Tracked with Nano-‘Hitchhikers,’ Scientists Say
Friday, March 22, 2013
The promise of repairing damaged hearts through regenerative medicine has yet to meet with clinical success. But a highly sensitive visualization technique may help speed that promise’s realization.
Human Brain Research Made Easier by Database
Thursday, March 21, 2013
Researchers will be able to access samples from more than 7,000 donated human brains to help study major brain diseases, thanks to a new on-line database, launched by the MRC.
Fibrocell/UCLA Study on Human Skin Cells Yields Promising Results
Thursday, March 21, 2013
Research has resulted in a discovery that may lead to a more predictable, commercially viable method of producing stable, induced pluripotent stem (iPS) cells from adult skin cells.
Designing Interlocking Building Blocks to Create Complex Tissues
Wednesday, March 20, 2013
New technique enables more precise design of tissue architecture.
Mesoblast Completes A$170m Private Placement
Tuesday, March 19, 2013
Company now has cash reserves of approximately A$332 million.
Vaccine Innovators Convene to Discuss New Technologies
Monday, March 18, 2013
New technologies to produce vaccines more safely, quickly and economically than traditional approaches are featured at the New Cells, New Vaccines VII: From Protein to Product international scientific conference.
|
|
|
|
|
|
